Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H22O7S |
Molecular Weight | 382.428 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CC2=C(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C=CS2)C=C1
InChI
InChIKey=BUXGTLNOWLNUKF-SOVHRIKKSA-N
InChI=1S/C18H22O7S/c1-23-11-4-2-10(3-5-11)8-14-12(6-7-26-14)24-18-17(22)16(21)15(20)13(9-19)25-18/h2-7,13,15-22H,8-9H2,1H3/t13-,15-,16+,17-,18-/m1/s1
Molecular Formula | C18H22O7S |
Molecular Weight | 382.428 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P31639 Gene ID: 6524.0 Gene Symbol: SLC5A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19137908 |
13.0 nM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Effects of AVE2268, a substituted glycopyranoside, on urinary glucose excretion and blood glucose in mice and rats. | 2008 |
|
Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease. | 2015 Aug |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:18:45 GMT 2023
by
admin
on
Fri Dec 15 17:18:45 GMT 2023
|
Record UNII |
Y0H7UPE4WJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C98083
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Y0H7UPE4WJ
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
9076
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
647834-15-9
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
300000036884
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
C91017
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
10068465
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY | |||
|
DTXSID10983395
Created by
admin on Fri Dec 15 17:18:45 GMT 2023 , Edited by admin on Fri Dec 15 17:18:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|